Mercaptopurine Oral Tablet 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Mercaptopurine: Oral tablet (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_266.JPG
Mercaptopurine 50mg Tab
Roxane Laboratories Inc
Pill Identification: 54 420 
Drug Image file default-drug-image.png
Mercaptopurine 50mg Tab
Drug Image file DrugItem_1886.JPG
Mercaptopurine 50mg Tab
Par Pharmaceutical Inc
Pill Identification: P 02 

What is this Medicine?

MERCAPTOPURINE, 6-MP (mer kap toe PYOOR een) is a chemotherapy drug. It interferes with the growth of cancer cells and can reduce immune system activity. It is used to treat certain types of acute leukemia.

Similar Brand Name Drugs : Purinethol: Oral tablet (50mg)
CVS Pharmacy Patient Statistics for Mercaptopurine: Oral tablet(50mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Mercaptopurine 50mg Tablet

NDC: 000544581
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Lymphocytic Leukemia (ALL)

Sometimes used for but not FDA approved for the following conditions:
Acute Myelogenous Leukemia (AML), Crohn's Disease, Chronic Myelogenous Leukemia (CML), Ulcerative Colitis

Storage Information
Store in a dry place
Store at controlled room temperature (between 68 and 77 degrees F)
Mercaptopurine 50mg Tablet
Drug Image file DrugItem_266.JPG
Roxane Laboratories Inc
Pill Identification: 54 420 
Shape: round
Color: white

Reported Side Effects for Mercaptopurine 50mg Tablet

Low White Blood Cell Counts Incidence:
2.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
3.3%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
7.4%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mercaptopurine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5